• 中国核心期刊数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

快速检索引用检索图表检索高级检索

• 投稿 • 上一篇    下一篇

太芪培元颗粒对气阴两虚肺肾不足型HIV感染者TLR-4影响的研究

艾合买提.阿不都热依木,舒占钧,马建萍,马秀兰,张颖,曾琳,李静茹,魏叶叶   

  1. 新疆医科大学附属中医医院,新疆医科大学附属中医医院,新疆医科大学附属中医医院,新疆医科大学附属中医医院,新疆医科大学附属中医医院,新疆医科大学附属中医医院,新疆医科大学附属中医医院,新疆医科大学
  • 收稿日期:2017-11-03 修回日期:2017-11-03 出版日期:2017-12-25
  • 基金资助:
    国家中医临床研究基地建设科研专项课题(项目编号:JDZX2012163;项目名称:平艾合剂1号方治疗艾滋病气阴两虚型研究);国家中医药管理局中医药防治重大疑难疾病临床服务能力建设项目(项目编号:201409;项目名称:新疆维吾尔族HIV-1的基因变异及宿主遗传背景与耐药的相关性研究)

Effect of Taiqipeiyuan Granules on TLR-4 Receptor of HIV-infected Patients Who were Deficency of both Qi-yin and Lung-kidney

aihemaiti·abudureyimu,shuzhanjun,majianping,maxiulan,zhangying,zenglin,lijingru and weiyeye   

  1. Traditional Chinese Medical Hospital affiliated to XinJiang Medical University,Traditional Chinese Medical Hospital affiliated to XinJiang Medical University,Traditional Chinese Medical Hospital affiliated to XinJiang Medical University,Traditional Chinese Medical Hospital affiliated to XinJiang Medical University,Traditional Chinese Medical Hospital affiliated to XinJiang Medical University,Traditional Chinese Medical Hospital affiliated to XinJiang Medical University,Traditional Chinese Medical Hospital affiliated to XinJiang Medical University,XinJiang Medical University
  • Received:2017-11-03 Revised:2017-11-03 Online:2017-12-25

摘要: 目的:观察太芪培元颗粒对气阴两虚肺肾不足型CD4+T淋巴细胞>350个·uL-1的HIV感染者的临床疗效。方法:采用队列研究,将108例HIV感染者根据是否服用太芪培元颗粒分为暴露组及非暴露组。观察6个月,对比两组患者的CD4+T淋巴细胞、HIV-RNA病毒载量、中医症状体征积分、Toll样受体-4(toll like receptor-4,TLR-4)、白介素-10(IL-10)等指标的差异。结果:经过6个月的治疗,暴露组比非暴露组的中医症状体征积分、TLR-4受体指标变化差异有统计学意义(P<0.05)。CD4+T淋巴细胞、HIV-RNA病毒载量、IL-10等指标差异无统计学意义(P>0.05)。结论:运用太芪培元颗粒治疗气阴两虚肺肾不足型CD4+T淋巴细胞>350个· uL-1HIV的感染者,可以改善患者临床症状,稳定患者CD4+T淋巴细胞计数,抑制TLR-4受体。太芪培元颗粒可能是通过机体免疫调节的过程发挥作用。

Abstract: Objective:To observe the curative effect of taiqipeiyuan granules to HIV-infected patients with CD4+ T lymphocytes>350·μL-1, who were deficiency of both qi-yin and lung-kidney.Methods:One hundred and eight HIV-infected patients in this cohort study were divided into two groups as exposure group and non-exposed group according to whether taking taiqipeiyuan granules.The exposure group was taking taiqipeiyuan granules, the non-exposed group without taking taiqipeiyuan granules. After 6 months, to observe the difference between two groups of patients with CD4+ T lymphocytes,HIV-RNA viral load,TCM symptom score,TLR-4 receptor,IL-10 and other indicators.Results:After 6 months of treatment, the difference between the two groups in TCM symptom score and TLR-4 receptor were statistically significant(P<0.05).The difference between the two groups in CD4+ T cells,HIV-RNA viral load,IL-10 and so on were not statistically significant. Conclusion:Taiqipeiyuan granules can improve the clinical symptoms of HIV-infected patients with CD4+T lymphocytes>350·uL-1, stabilize CD4+ T lymphocyte count and inhibit TLR-4 receptor.Taiqipeiyuan granules may play a role in regulating the immune process.